课题基金 / 基金详情

PRESENILIN DOMAINS AND RECONSTITUTION OF CATALYSIS

PRESENILIN DOMAINS AND RECONSTITUTION OF CATALYSIS
早老素结构域和催化重建
批准号:
7269823
负责人:
SAMUEL E. GANDY
金额:
$32.95万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2010-06-30

项目摘要

项目成果

SAMUEL E. GANDY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): gamma-Secretase is the proteolytic activity that catalyzes the final step in the generation of the amyloid beta-peptide (AP) from the transmembrane Alzheimer amyloid precursor protein (APP). Growing evidence suggests that the presenilin proteins (PS1 and PS2) are required in order for gamma-secretase cleavage to occur. The PS proteins are endoproteolytically cleaved, generating an N-terminal fragment (NTF) and a C-terminal fragment (CTF). The NTF and CTF remain stably associated as heterodimers and assemble together with the partner proteins known as nicastrin, aph-1, and pen-2 proteins in order to form the high molecular weight (approximately 10/6 kDa) complex that is believed to constitute the functional gamma secretase. Gamma-Secretase cleavage is unusual in that it apparently occurs within the anhydrous environment of the membrane bilayer. The realization that numerous transmembrane proteins are processed in a similar fashion has inspired the formulation of a general concept: regulated intramembrane proteolysis, or RIP. The general goal of this proposal is to advance our understanding of the structure and function of PS proteins. In Aim 1 mutant PS molecules will be designed that permit the localization of domains that are important for (i) endoproteolytic processing of PS, and for (ii) intramembranous processing of APP to liberate Abeta40, Abeta42, and the APP intracellular domain (AICD). Successive truncation and point mutagenesis strategies will be utilized. In Aim 2, we will elucidate the conditions required for generating aspartyl proteinase activity from recombinant PS1 and its partners nicastrin, aph-1 and pen-2, following their expression in insect cells. This investigation will permit the identification of the minimal functional unit for gamma-secretase activity and potentially support the notion that PS1 is indeed the catalytic component of the gamma-secretase complex.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
  • 批准号:
    10378457
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    SAMUEL E. GANDY
  • 依托单位:
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
  • 批准号:
    9911993
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    SAMUEL E. GANDY
  • 依托单位:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
  • 批准号:
    9220567
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    SAMUEL E. GANDY
  • 依托单位:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
  • 批准号:
    8596270
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    SAMUEL E. GANDY
  • 依托单位:
海外基金